Immuneering Corporation

IMRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.44

-$0.04 (-0.89%)

At close: Sep 21, 2026, 4:00 PM ET

$4.50

+$0.06 (+1.35%)

Pre-market: Sep 22, 2026, 5:54 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $161.18M

Enterprise Value $14.92M

Beta 0.39

Average Volume 1.24M

Shares Outstanding (Diluted) 64.7M

Shares Change YoY 79.79%

Institutional Ownership 45.32%

Exchange NASDAQ

ISIN US45254E1073

Price Performance

Price Change 1M -16.1%

Price Change 3M -2.2%

Price Change 6M -16.5%

Price Change YTD -32.9%

Price Change 1Y -49.1%

Price Change 3Y -42.1%

Price Change 5Y -83.8%

1M CAGR (ann.) -1.6%

1Y CAGR (ann.) -50.7%

5Y CAGR (ann.) -28.3%

All-Time CAGR -23.5%

Valuation

PE Ratio -4.27

Forward PE N/A

PEG Ratio -0.06

Forward PEG -0.35

PS Ratio N/A

Forward PS 7.10

PB Ratio 0.85

P/FCF Ratio -0.00

P/Adj. FCF Ratio -0.00

P/OCF Ratio -5.05

EV/Sales N/A

EV/EBIT -0.24

EV/EBITDA -0.24

EV/FCF -0.00

Earnings Yield -23.4%

FCF Yield -21754.3%

Adj. FCF Yield -23779.7%

Financial Health

Net Cash $149.9M

Total Debt $3.63M

Cash & Short-Term Investments $149.9M

Total Assets $202.06M

Current Ratio 19.47

Quick Ratio 19.47

Debt / Equity Ratio 0.02

Debt / EBITDA -0.06

Debt / FCF -0.00

OCF / Debt -9,620.37

Interest Coverage 0.00

Altman Z-Score 6.26

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -9.3%

Returns

Return on Assets -28.4%

Return on Equity -27.1%

Return on Invested Capital -32.6%

Return on Capital Employed -32.7%

Return on Tangible Assets -29.4%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y -98.0%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 27.0%

EPS CAGR 5Y -60.9%

EPS CAGR 10Y N/A

FCF CAGR 3Y -149.3%

FCF CAGR 5Y -99.3%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 11

EPS Growth Next 3Y 7.4%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$0.29

EPS Growth Est (next Q) -23.7%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $15.50

Price Target Upside 249.1%

Cash Flow

Operating Cash Flow $-34.96B

Free Cash Flow $-35.06B

Adj. Free Cash Flow $-38.33B

FCF Per Share -$0.88

OCF Per Share -$0.88

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-793.21K

Operating Income $-63.47M

EBITDA $-61.37M

Net Income $-57.28M

EPS (Diluted) -$1.04

Revenue / Employee N/A

Profit / Employee $-1M

Employees 57